Quarry LP lessened its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report) by 30.9% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 356 shares of the company’s stock after selling 159 shares during the period. Quarry LP’s holdings in U.S. Physical Therapy were worth $30,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Canada Pension Plan Investment Board acquired a new position in shares of U.S. Physical Therapy in the second quarter worth about $28,000. Innealta Capital LLC acquired a new stake in shares of U.S. Physical Therapy during the second quarter valued at about $30,000. Quest Partners LLC raised its holdings in shares of U.S. Physical Therapy by 2,808.3% in the 2nd quarter. Quest Partners LLC now owns 349 shares of the company’s stock valued at $32,000 after buying an additional 337 shares during the period. Ridgewood Investments LLC purchased a new stake in U.S. Physical Therapy during the 2nd quarter worth approximately $51,000. Finally, KBC Group NV raised its stake in shares of U.S. Physical Therapy by 68.6% in the third quarter. KBC Group NV now owns 774 shares of the company’s stock valued at $66,000 after acquiring an additional 315 shares in the last quarter.
U.S. Physical Therapy Stock Down 1.7 %
Shares of U.S. Physical Therapy stock opened at $94.06 on Friday. The company has a market cap of $1.42 billion, a P/E ratio of 100.06, a P/E/G ratio of 4.34 and a beta of 1.46. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 1 year low of $76.18 and a 1 year high of $113.63. The stock has a 50-day moving average price of $89.08 and a 200 day moving average price of $90.09.
U.S. Physical Therapy Announces Dividend
Wall Street Analyst Weigh In
Several equities research analysts recently commented on the stock. JPMorgan Chase & Co. lifted their price target on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 3rd. StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. Barrington Research reissued an “outperform” rating and issued a $108.00 price objective on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. Finally, Bank of America reissued a “neutral” rating and issued a $90.00 target price (down previously from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th.
View Our Latest Stock Analysis on U.S. Physical Therapy
Insider Transactions at U.S. Physical Therapy
In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of U.S. Physical Therapy stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $96.25, for a total value of $49,665.00. Following the completion of the sale, the chief financial officer now owns 20,469 shares in the company, valued at $1,970,141.25. The trade was a 2.46 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Eric Joseph Williams sold 2,000 shares of the company’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $95.84, for a total value of $191,680.00. Following the sale, the insider now owns 14,814 shares of the company’s stock, valued at $1,419,773.76. The trade was a 11.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 7,412 shares of company stock valued at $706,605. Corporate insiders own 1.70% of the company’s stock.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Further Reading
- Five stocks we like better than U.S. Physical Therapy
- 3 Best Fintech Stocks for a Portfolio Boost
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- What is a SEC Filing?
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- What is the Australian Securities Exchange (ASX)
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.